申请人:PFIZER INC.
公开号:EP0089781A2
公开(公告)日:1983-09-28
Bicyclic fused benzenoid compounds of the formula
and pharmaceutically acceptable cationic and acid addition salts thereof, where M is O, CH2 or NR6; R6 is hydrogen, formyl, carbobenzyloxy or certain carboalkoxyalkyl, alkanoyl, alkyl, aralkyl or aralkylcarbonyl groups;
A' is:
(1) A where one of A and B is hydrogen such that when A is hydrogen, B is C(R2R3) (CH2)fO and f is 1 or 2; when B is hydrogen, A is C(R2R3)(CH2)fO and f is 0 or 1, when taken together A and OR1 form a lactone or certain derivatives thereof;
(2) A' is HOCH2CONR12R13;
(3) A' is 03;
O is CO2R7, CORe, C(OH)R8R9, CN, CONR12R13, CH2NR12R13, CH2NHCOR14, CH2NHSO2R17 or 5-tatrazoyl;
03 is spiro -
5-tetrazolyl, CH2CONHCOR7, COOH or certain ester, amide, carboximido or sulfonimido derivatives thereof, CONHOH, CONHCONH2, or COCH2O4 where O4 is CN or COOH or certain esters thereof;
R1 is hydrogen, benzyl or certain acyl groups; R4 is hydrogen, certain alkyl or certain aralkyl groups; R5 is hydrogen or certain alkyl groups; Z is (C1-C9)alkylene, optionally interrupted by O, S, SO or S02; and W is hydrogen, methyl, certain aryl or cycloalkyl groups; useful in mammals as analgesics, tranquilizers, antiemetic agents, diuretics, anticonvulsants, antidiarrheals, antitussives, in treatment of glaucoma, and intermediates therefore.
式中的双环融合苯化合物
及其药学上可接受的阳离子盐和酸加成盐,其中 M 是 O、CH2 或 NR6;R6 是氢、甲酰基、苄氧基或某些羧烷氧基烷基、烷酰基、烷基、芳基或芳烷基羰基;
A' 是
(1) A 和 B 中的一个是氢,这样当 A 是氢时,B 是 C(R2R3)(CH2)fO 且 f 是 1 或 2;当 B 是氢时,A 是 C(R2R3)(CH2)fO 且 f 是 0 或 1,当 A 和 OR1 结合在一起时形成内酯或其某些衍生物;
(2) A'是 HOCH2CONR12R13;
(3) A' 是 03;
O 是 CO2R7、CORe、C(OH)R8R9、CN、CONR12R13、CH2NR12R13、CH2NHCOR14、CH2NHSO2R17 或 5-tatrazoyl;
03 是螺
5-四唑基、CH2CONHCOR7、COOH 或其某些酯、酰胺、羧酰亚胺或磺酰亚胺衍生物、CONHOH、CONHCONH2 或 COCH2O4,其中 O4 为 CN 或 COOH 或其某些酯;
R1 是氢、苄基或某些酰基;R4 是氢、某些烷基或某些芳烷基;R5 是氢或某些烷基;Z 是 (C1-C9)亚烷基,可选被 O、S、SO 或 S02 中断;W 是氢、甲基、某些芳基或环烷基;在哺乳动物中可用作镇痛剂、镇静剂、止吐药、利尿剂、抗惊厥药、止泻药、抗惊厥药、治疗青光眼的药物及其中间体。